| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxiredoxin VI | 13 | 2014 | 18 | 1.860 |
Why?
|
| Peroxidases | 13 | 2013 | 28 | 1.550 |
Why?
|
| Oxidative Stress | 20 | 2018 | 718 | 1.110 |
Why?
|
| Glutathione | 16 | 2018 | 343 | 0.920 |
Why?
|
| Peroxiredoxins | 16 | 2022 | 34 | 0.910 |
Why?
|
| Glutathione Transferase | 7 | 2016 | 166 | 0.850 |
Why?
|
| Signal Transduction | 8 | 2018 | 2689 | 0.760 |
Why?
|
| Lung | 15 | 2007 | 849 | 0.740 |
Why?
|
| Reactive Oxygen Species | 14 | 2019 | 499 | 0.710 |
Why?
|
| Isoflavones | 2 | 2019 | 31 | 0.710 |
Why?
|
| Oxidation-Reduction | 16 | 2022 | 567 | 0.690 |
Why?
|
| Endothelium, Vascular | 8 | 2009 | 371 | 0.610 |
Why?
|
| Nitric Oxide | 8 | 2014 | 382 | 0.590 |
Why?
|
| Phospholipases A2 | 5 | 2009 | 32 | 0.580 |
Why?
|
| Energy Metabolism | 3 | 2019 | 222 | 0.550 |
Why?
|
| Ischemia | 6 | 2005 | 229 | 0.510 |
Why?
|
| Glutathione S-Transferase pi | 6 | 2018 | 53 | 0.510 |
Why?
|
| Hydrogen Peroxide | 6 | 2013 | 168 | 0.500 |
Why?
|
| Azo Compounds | 3 | 2010 | 33 | 0.490 |
Why?
|
| Calcium | 8 | 2016 | 929 | 0.480 |
Why?
|
| Lung Neoplasms | 4 | 2019 | 1172 | 0.450 |
Why?
|
| Cell Membrane | 3 | 2012 | 524 | 0.440 |
Why?
|
| Nitric Oxide Synthase | 3 | 2014 | 163 | 0.430 |
Why?
|
| Mitochondria | 5 | 2019 | 643 | 0.380 |
Why?
|
| Brain Injuries | 1 | 2014 | 268 | 0.370 |
Why?
|
| Recovery of Function | 1 | 2014 | 506 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2014 | 282 | 0.340 |
Why?
|
| Animals | 40 | 2022 | 20880 | 0.340 |
Why?
|
| Mice | 28 | 2022 | 8474 | 0.310 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2019 | 284 | 0.310 |
Why?
|
| Proteasome Inhibitors | 2 | 2018 | 29 | 0.310 |
Why?
|
| Phospholipases | 1 | 2007 | 12 | 0.300 |
Why?
|
| Cell Line, Tumor | 9 | 2019 | 1851 | 0.290 |
Why?
|
| Protein Binding | 7 | 2016 | 1027 | 0.290 |
Why?
|
| Cysteine | 5 | 2022 | 112 | 0.280 |
Why?
|
| Pulmonary Circulation | 2 | 2005 | 79 | 0.280 |
Why?
|
| NADPH Oxidases | 3 | 2005 | 80 | 0.270 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2019 | 332 | 0.250 |
Why?
|
| Rats | 15 | 2011 | 5300 | 0.250 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2018 | 27 | 0.240 |
Why?
|
| Endothelial Cells | 5 | 2010 | 384 | 0.230 |
Why?
|
| Biomarkers | 3 | 2019 | 1593 | 0.220 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 9 | 0.210 |
Why?
|
| Rad51 Recombinase | 1 | 2022 | 16 | 0.210 |
Why?
|
| Humans | 34 | 2022 | 68549 | 0.210 |
Why?
|
| para-Aminobenzoates | 3 | 2010 | 27 | 0.210 |
Why?
|
| Apoptosis | 8 | 2019 | 1641 | 0.210 |
Why?
|
| Kinetics | 6 | 2010 | 1047 | 0.200 |
Why?
|
| Serpins | 3 | 2019 | 205 | 0.200 |
Why?
|
| Unfolded Protein Response | 3 | 2019 | 70 | 0.200 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 2 | 2012 | 20 | 0.200 |
Why?
|
| Phospholipids | 6 | 2007 | 108 | 0.190 |
Why?
|
| Membrane Proteins | 3 | 2011 | 617 | 0.190 |
Why?
|
| Neoplasms | 6 | 2014 | 1664 | 0.190 |
Why?
|
| Hyperoxia | 3 | 2006 | 27 | 0.190 |
Why?
|
| Multiple Myeloma | 2 | 2018 | 92 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1070 | 0.180 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2019 | 48 | 0.170 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 40 | 0.170 |
Why?
|
| Mice, Knockout | 10 | 2018 | 1692 | 0.170 |
Why?
|
| Indenes | 1 | 2018 | 6 | 0.160 |
Why?
|
| Models, Molecular | 4 | 2012 | 546 | 0.160 |
Why?
|
| Oxygen | 3 | 2006 | 386 | 0.160 |
Why?
|
| Sulfhydryl Compounds | 4 | 2013 | 73 | 0.160 |
Why?
|
| Circular Dichroism | 2 | 2009 | 99 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 53 | 0.160 |
Why?
|
| Glutaminase | 1 | 2017 | 7 | 0.150 |
Why?
|
| Thiadiazoles | 1 | 2017 | 7 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 2 | 2016 | 148 | 0.150 |
Why?
|
| Benzeneacetamides | 1 | 2017 | 11 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2014 | 432 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 10 | 2018 | 2791 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 65 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2017 | 152 | 0.140 |
Why?
|
| HL-60 Cells | 3 | 2010 | 50 | 0.140 |
Why?
|
| 4-Aminobenzoic Acid | 3 | 2010 | 30 | 0.140 |
Why?
|
| Mutation | 3 | 2012 | 1213 | 0.140 |
Why?
|
| Protein S | 1 | 2016 | 9 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2018 | 201 | 0.140 |
Why?
|
| Extracellular Space | 1 | 2016 | 121 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 79 | 0.130 |
Why?
|
| MCF-7 Cells | 2 | 2013 | 80 | 0.130 |
Why?
|
| Homeostasis | 3 | 2014 | 291 | 0.130 |
Why?
|
| Phospholipases A | 2 | 2005 | 41 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2010 | 2673 | 0.130 |
Why?
|
| Alleles | 2 | 2014 | 386 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 94 | 0.130 |
Why?
|
| Cell Line | 5 | 2016 | 1752 | 0.130 |
Why?
|
| Immunoblotting | 3 | 2010 | 254 | 0.120 |
Why?
|
| Cell Movement | 2 | 2014 | 630 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 94 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 65 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2014 | 83 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2009 | 112 | 0.120 |
Why?
|
| Bone Marrow | 1 | 2014 | 168 | 0.120 |
Why?
|
| Glutathione Disulfide | 2 | 2012 | 31 | 0.110 |
Why?
|
| Fibroblasts | 3 | 2022 | 902 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2005 | 1663 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2013 | 3 | 0.110 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 778 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2018 | 1174 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 307 | 0.110 |
Why?
|
| Tubulin | 1 | 2013 | 60 | 0.110 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2013 | 40 | 0.110 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cytoprotection | 1 | 2012 | 39 | 0.110 |
Why?
|
| Transgenes | 1 | 2012 | 92 | 0.110 |
Why?
|
| Cisplatin | 2 | 2012 | 192 | 0.110 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 59 | 0.110 |
Why?
|
| Glutathione Peroxidase | 3 | 2007 | 39 | 0.110 |
Why?
|
| Thioredoxins | 2 | 2009 | 26 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 113 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 134 | 0.100 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2013 | 112 | 0.100 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2011 | 6 | 0.100 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2012 | 61 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 659 | 0.100 |
Why?
|
| Substrate Specificity | 2 | 2009 | 234 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 206 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2009 | 272 | 0.100 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 301 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2014 | 296 | 0.100 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2011 | 62 | 0.100 |
Why?
|
| Oxidoreductases | 1 | 2011 | 117 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 332 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 420 | 0.090 |
Why?
|
| Liposomes | 2 | 2009 | 107 | 0.090 |
Why?
|
| Hydrolysis | 2 | 2008 | 144 | 0.090 |
Why?
|
| Models, Biological | 3 | 2016 | 981 | 0.090 |
Why?
|
| Catalysis | 2 | 2008 | 123 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 163 | 0.090 |
Why?
|
| Nitric Oxide Donors | 1 | 2010 | 54 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 107 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 742 | 0.090 |
Why?
|
| Obstetric Labor Complications | 1 | 2010 | 20 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 201 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 41 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2009 | 20 | 0.090 |
Why?
|
| Chorioamnionitis | 1 | 2010 | 40 | 0.090 |
Why?
|
| Pulmonary Alveoli | 2 | 2009 | 62 | 0.090 |
Why?
|
| Prodrugs | 1 | 2010 | 54 | 0.090 |
Why?
|
| RNA Interference | 1 | 2010 | 266 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2010 | 141 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 102 | 0.090 |
Why?
|
| Catalase | 1 | 2009 | 85 | 0.090 |
Why?
|
| Fever | 1 | 2010 | 96 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 300 | 0.080 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 2 | 2006 | 16 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2010 | 282 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 334 | 0.080 |
Why?
|
| Paraquat | 2 | 2006 | 8 | 0.080 |
Why?
|
| Adenosine Diphosphate | 2 | 2022 | 66 | 0.080 |
Why?
|
| Male | 14 | 2019 | 37283 | 0.080 |
Why?
|
| Macrophages | 2 | 2009 | 647 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 108 | 0.080 |
Why?
|
| Immunoprecipitation | 4 | 2012 | 132 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 274 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2013 | 791 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 250 | 0.080 |
Why?
|
| Antioxidants | 3 | 2005 | 304 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 621 | 0.080 |
Why?
|
| Meglumine | 1 | 2007 | 16 | 0.070 |
Why?
|
| Time Factors | 3 | 2005 | 4655 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 128 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 136 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 204 | 0.070 |
Why?
|
| Membrane Lipids | 3 | 1987 | 31 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2014 | 3187 | 0.070 |
Why?
|
| Hypoxia | 2 | 2005 | 169 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 286 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 618 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 331 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2007 | 34 | 0.070 |
Why?
|
| Epithelial Cells | 4 | 2013 | 431 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2009 | 2083 | 0.070 |
Why?
|
| Cocaine | 1 | 2011 | 555 | 0.070 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 99 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 200 | 0.070 |
Why?
|
| Aged | 3 | 2019 | 14842 | 0.070 |
Why?
|
| Lung Injury | 1 | 2006 | 38 | 0.070 |
Why?
|
| Oxidants | 2 | 2003 | 48 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 4 | 2006 | 17 | 0.060 |
Why?
|
| Electrons | 1 | 2005 | 25 | 0.060 |
Why?
|
| Young Adult | 2 | 2014 | 5710 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2006 | 117 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 238 | 0.060 |
Why?
|
| Calcium Channels, T-Type | 1 | 2004 | 1 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 248 | 0.060 |
Why?
|
| Ion Transport | 1 | 2004 | 26 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 27 | 0.060 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 62 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2006 | 175 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 155 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 631 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2004 | 295 | 0.060 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 52 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1533 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 86 | 0.050 |
Why?
|
| Aorta | 1 | 2004 | 316 | 0.050 |
Why?
|
| Ribose | 1 | 2022 | 1 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 23 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 39 | 0.050 |
Why?
|
| Homologous Recombination | 1 | 2022 | 13 | 0.050 |
Why?
|
| Dimerization | 3 | 2008 | 99 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2002 | 29 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2004 | 291 | 0.050 |
Why?
|
| DNA Repair | 1 | 2022 | 127 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 765 | 0.050 |
Why?
|
| Ligands | 2 | 2014 | 317 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 8904 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 901 | 0.050 |
Why?
|
| Female | 6 | 2014 | 38021 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2012 | 304 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 322 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1446 | 0.040 |
Why?
|
| Stress, Mechanical | 3 | 2005 | 208 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 597 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 93 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1293 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2009 | 1200 | 0.040 |
Why?
|
| Membrane Potentials | 3 | 2004 | 200 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 140 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 415 | 0.040 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2018 | 25 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 138 | 0.040 |
Why?
|
| Adult | 2 | 2014 | 21379 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 48 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 84 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2006 | 1033 | 0.040 |
Why?
|
| Protein Folding | 2 | 2009 | 82 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 110 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2017 | 47 | 0.040 |
Why?
|
| Necrosis | 2 | 2009 | 239 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 852 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 261 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 260 | 0.040 |
Why?
|
| Pulmonary Surfactants | 2 | 2007 | 41 | 0.030 |
Why?
|
| Fluorescent Dyes | 4 | 2003 | 191 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 21119 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1082 | 0.030 |
Why?
|
| Lipid Peroxides | 2 | 2007 | 19 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1745 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 280 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2005 | 16 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 166 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cromakalim | 2 | 2004 | 2 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 48 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 51 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 467 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 294 | 0.030 |
Why?
|
| Glutaredoxins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2007 | 308 | 0.030 |
Why?
|
| Nitrogen | 1 | 2013 | 57 | 0.030 |
Why?
|
| Lipoproteins, HDL | 2 | 1985 | 113 | 0.030 |
Why?
|
| NADP | 1 | 2013 | 39 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 24 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 68 | 0.030 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2004 | 954 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 247 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 314 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 139 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 160 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2011 | 75 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 249 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Labor Stage, First | 1 | 2010 | 5 | 0.020 |
Why?
|
| Seizures, Febrile | 1 | 2010 | 10 | 0.020 |
Why?
|
| Glutathione Reductase | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cell Shape | 1 | 2010 | 37 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 189 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 55 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2009 | 7 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1174 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2009 | 30 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 306 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2009 | 21 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 99 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 50 | 0.020 |
Why?
|
| Threonine | 1 | 2009 | 47 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 99 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 91 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2009 | 138 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 329 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 175 | 0.020 |
Why?
|
| Indoles | 1 | 2009 | 146 | 0.020 |
Why?
|
| Endocytosis | 1 | 2009 | 113 | 0.020 |
Why?
|
| Sphingolipids | 1 | 2011 | 337 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 270 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 434 | 0.020 |
Why?
|
| Sorbitol | 1 | 2007 | 3 | 0.020 |
Why?
|
| Ceramides | 1 | 2011 | 578 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 267 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 215 | 0.020 |
Why?
|
| Amino Sugars | 1 | 2007 | 12 | 0.020 |
Why?
|
| Proteomics | 1 | 2009 | 246 | 0.020 |
Why?
|
| Membranes, Artificial | 2 | 1985 | 88 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 85 | 0.020 |
Why?
|
| Influenza A virus | 1 | 1987 | 13 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2007 | 137 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 381 | 0.020 |
Why?
|
| Parturition | 1 | 2007 | 15 | 0.020 |
Why?
|
| Sepsis | 1 | 2010 | 233 | 0.020 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2007 | 17 | 0.020 |
Why?
|
| Mesothelioma | 1 | 2007 | 21 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 624 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2006 | 1 | 0.020 |
Why?
|
| Protein Carbonylation | 1 | 2006 | 2 | 0.020 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2005 | 9 | 0.020 |
Why?
|
| Sepharose | 1 | 2005 | 18 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1549 | 0.020 |
Why?
|
| Nickel | 1 | 2005 | 18 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 47 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 30 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 50 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2005 | 50 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Glyburide | 1 | 2005 | 19 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1034 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 20 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 80 | 0.020 |
Why?
|
| Lysosomes | 1 | 2006 | 136 | 0.020 |
Why?
|
| Light | 1 | 2005 | 152 | 0.020 |
Why?
|
| Mibefradil | 1 | 2004 | 1 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 107 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2004 | 58 | 0.020 |
Why?
|
| Nifedipine | 1 | 2004 | 40 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2004 | 32 | 0.020 |
Why?
|
| Rheology | 1 | 2004 | 25 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1985 | 162 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 75 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2005 | 220 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 42 | 0.020 |
Why?
|
| Cell Division | 1 | 2005 | 541 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2004 | 55 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2003 | 4 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 77 | 0.010 |
Why?
|
| Capillaries | 1 | 2004 | 105 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 2455 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2003 | 25 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 137 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2003 | 85 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 160 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 68 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 242 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2004 | 74 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 67 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 167 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2003 | 13 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 138 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 40 | 0.010 |
Why?
|
| Pyrenes | 1 | 2003 | 15 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 55 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 489 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 196 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 714 | 0.010 |
Why?
|
| Fluorescence | 1 | 2003 | 104 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 312 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 282 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 492 | 0.010 |
Why?
|
| Partial Pressure | 1 | 2002 | 19 | 0.010 |
Why?
|
| Lanthanum | 1 | 2002 | 3 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 361 | 0.010 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2002 | 11 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2002 | 13 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2002 | 40 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 946 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 88 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2002 | 54 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1982 | 38 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 35 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2002 | 59 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 66 | 0.010 |
Why?
|
| Sphingomyelins | 1 | 1982 | 106 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 155 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2002 | 91 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 204 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1055 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 196 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 371 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 473 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 782 | 0.010 |
Why?
|
| Rimantadine | 1 | 1987 | 3 | 0.000 |
Why?
|
| Viral Matrix Proteins | 1 | 1987 | 10 | 0.000 |
Why?
|
| Membranes | 1 | 1987 | 26 | 0.000 |
Why?
|
| Photochemistry | 1 | 1987 | 46 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1987 | 70 | 0.000 |
Why?
|
| Chickens | 1 | 1987 | 232 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1987 | 149 | 0.000 |
Why?
|
| Membrane Fluidity | 1 | 1982 | 13 | 0.000 |
Why?
|
| Fluorescence Polarization | 1 | 1982 | 14 | 0.000 |
Why?
|
| Energy Transfer | 1 | 1982 | 25 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1982 | 362 | 0.000 |
Why?
|